Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Jul 27 1999
WASHINGTON, D.C., (July 27, 1999) The Biotechnology Industry Organization (BIO) launched radio advertisements today to help focus Congress and the public on...
Jul 20 1999
WASHINGTON, D.C. (July 20, 1999) Mike Phillips, formerly with the National Academy of Sciences, has joined the Biotechnology Industry Organization (BIO) as...
Jul 13 1999
WASHINGTON, D.C. (July 12, 1999) Biotechnology is delivering on promises to make farming more efficient. Those are the findings of the first-ever analysis...
Jul 8 1999
WHO: Carl B. FeldbaumBiotechnology Industry Organization WHEN: 10:00 A.M. Wednesday, July 14, 1999 WHERE: National Press Club Morning Newsmakers Breakfast...
Jul 8 1999
July 7, 1999 (Washington, D.C.) -- The first-ever analysis of biotechnology's impact on crop protection and benefits to farm production will be released next...
Jul 2 1999
(WASHINGTON, D.C., July 2, 1999) The Biotechnology Industry Organization (BIO) today praised U.S. Rep. Jennifer Dunn (R-Wash.) for introducing a House bill (H....
Jul 1 1999
WASHINGTON, D.C. (July 1, 1998) - At its annual membership meeting June 16, 1998 in New York City, the Biotechnology Industry Organization (BIO) elected 13...
Jun 30 1999
WASHINGTON, DC (June 30, 1999) -- The American Hospital Association and the Biotechnology Industry Organization (BIO) have signed a memorandum of...
Jun 29 1999
(WASHINGTON, D.C., June 29, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in response to...


Biotechnology News

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and...

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of...

September 1, 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (...